Intraperitoneal PD-1 Monoclonal Antibody for Advanced Primary Liver Cancer With Malignant Ascites
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Intraperitoneal PD-1 monoclonal antibody for the treatment of advanced primary liver cancer with malignant ascites: a single-arm, single-center, phase Ib trial
ESMO Open 2024 Jan 08;9(1)102206, C Chen, Z Li, X Xiong, A Yao, S Wang, X Liu, X Liu, J WangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.